VAL - this cancer trial update was positive, (but i'm always wary of crap companies who think their shareholders are sooo stupid and have to headline their announcement's rather desperately 'Positive announcement')
V high risk but this could so easily get snapped up because a £5m Mkt Cap just doesn't make sense for a cancer drug showing safety and efficacy
Dr Satu Vainikka, CEO of ValiRx, commented: "VAL201 has demonstrated disease stabilisation, with a lower dose than was predicted by our preclinical evaluations. We anticipate that by increasing the dosage we will show a high level of efficacy without compromising the safety and tolerability shown to date to meet the needs of those patients currently under-served by current therapies. ValiRx is entering a very exciting phase, which should result in the crystallisation of substantial value".
http://www.investegate.co.uk/valirx...-positive-val201-results/201701110700068311T/
V high risk but this could so easily get snapped up because a £5m Mkt Cap just doesn't make sense for a cancer drug showing safety and efficacy
Dr Satu Vainikka, CEO of ValiRx, commented: "VAL201 has demonstrated disease stabilisation, with a lower dose than was predicted by our preclinical evaluations. We anticipate that by increasing the dosage we will show a high level of efficacy without compromising the safety and tolerability shown to date to meet the needs of those patients currently under-served by current therapies. ValiRx is entering a very exciting phase, which should result in the crystallisation of substantial value".
http://www.investegate.co.uk/valirx...-positive-val201-results/201701110700068311T/